Preferred Label : Machado-joseph disease;
Symbol : MJD;
CISMeF acronym : MJD; SCA3;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : SCA3; Azorean neurologic disease; Spinopontine atrophy; Spinocerebellar atrophy III; Spinocerebellar ataxia 3; Nigrospinodentatal degeneration;
Description : Machado-Joseph disease, named for affected families of Azorean extraction, is an autosomal
dominant progressive neurologic disorder characterized principally by ataxia, spasticity,
and ocular movement abnormalities. Although independently described as a seemingly
separate disorder, spinocerebellar ataxia-3 is now known to be the same as Machado-Joseph
disease. Three classic clinical subtypes of MJD are recognized: type 1 with early
onset and marked pyramidal and dystonic signs; type 2, or pure, with predominant cerebellar
ataxia; and type 3 with later-onset and peripheral neuropathy (Franca et al., 2008).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by trinucleotide repeat expansion (CAG)n in the ataxin-3 gene (MJD, 607047.0001);
Prefixed ID : #109150;
Origin ID : 109150;
UMLS CUI : C0024408;
- Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- DO Cross reference
- False automatic mappings
- Genes related to phenotype
- HPO term(s)
- ORDO concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT